Point72 Middle East FZE’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-75,300
Closed -$6.2M 815
2023
Q4
$6.2M Buy
75,300
+58,000
+335% +$4.42M 0.18% 134
2023
Q3
$1.36M Buy
17,300
+900
+5% +$75.3K 0.04% 471
2023
Q2
$1.44M Buy
16,400
+700
+4% +$60.3K 0.04% 472
2023
Q1
$1.27M Buy
15,700
+8,000
+104% +$652K 0.04% 437
2022
Q4
$598K Buy
+7,700
New +$624K 0.03% 667

Other funds holding MDT

Point72 Middle East FZE's MDT Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Medtronic (MDT) in Q1 2024, closing a stake of 21,764 shares — an estimated $1.79M sold.

Point72 Middle East FZE first reported a position in MDT in Q4 2022 and held it in 3 quarters. The position peaked at $13.9M in Q1 2023. 2,076 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 21,764 Medtronic shares in Q1 2024, an estimated $1.79M.
  • Point72 Middle East FZE first reported a position in Medtronic in Q4 2022 and held it in 3 quarters.
  • Point72 Middle East FZE's Medtronic position peaked at $13.9M in Q1 2023.
  • 2,076 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.